September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an ...
September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...
September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...
September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...
September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...
In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...
Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...
September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...
September 11, 2023 — The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease ...
September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...
September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...